Navigation Links
ImaginAb and Singapore Radiopharmaceuticals Sign Master Service Agreement
Date:8/7/2012

LOS ANGELES and SINGAPORE, Aug. 7, 2012 /PRNewswire/ -- ImaginAb, Inc. a developer of in vivo molecular imaging agents based on its proprietary antibody fragment platform, today announced that it has signed a Master Service Agreement (MSA) with Singapore Radiopharmaceuticals Pte Ltd, a subsidiary of Fortis HealthCare.

"This agreement represents an important component of our expansion program in Singapore as we establish R&D and pre-clinical imaging capabilities there," said Christian Behrenbruch, Ph.D., Chief Executive Officer of ImaginAb. "Singapore Radiopharmaceuticals has an excellent track record in custom radiochemistry and cGMP product manufacturing and we are pleased to transition our ad hoc collaboration to a more robust alliance."

ImaginAb's technology enables antibodies to be re-engineered into smaller proteins (fragments) with fast kinetics suitable for diagnostic imaging, while maintaining target biospecificity. In this way, true companion in vivo diagnostics can be rapidly developed that enable target expression to be profiled in tissues in a non-invasive, whole-body manner. ImaginAb has over a dozen development programs with global biopharma companies to develop companion diagnostic imaging agents to therapeutic antibody drugs (in Phase I to BLA), as well as an internal pipeline targeting unmet clinical needs, such as the staging of metastatic prostate and pancreatic cancer.*

"ImaginAb has an exciting product pipeline and an extensive pharma client base in need of cGMP radiochemistry services for clinical trials in all corners of the world," said Dr. Nevil Chimon, CEO of Singapore Radiopharmaceuticals. "ImaginAb's presence in Singapore is a visible part of Singapore's growing footprint in molecular imaging and nuclear medicine."

About ImaginAb

ImaginAb is redefining therapeutic management by harnessing the power of antibody technology for in vivo imaging.  The company's proprieta
'/>"/>

SOURCE ImaginAb, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. ANSYS Signs Master Agreement with EADS to provide simulation tools to all its divisions
2. Life Technologies Signs Collaborative Agreement with Structural Genomics Consortium to Develop First Antibody Master Set for Epigenetic Studies
3. Beverly Hills Dentist, Dr. Zadeh, Receives 2011 Mastership Award from the Academy of General Dentistry
4. Accuray and Erasmus Medical Center Sign Master Research and Collaboration Agreement
5. Accuray and the German Cancer Research Center Sign Master Research and Collaboration Agreement
6. Paragon Bioservices, Inc. Wins The 2012 CMO Leadership Award
7. Leading Medical Technology Company Selects inContact to Transform Service Experience
8. MedVantx Pharmacy Services Receives Coveted VIPPS Accreditation (Verified Internet Pharmacy Practice Sites)
9. BioSurplus Forms New Division for Auction Services
10. TeNS Medical Services: Blogging for a Pain Free Future
11. Sysmex and Siemens Renew Global Partnership for Hemostasis Solutions and Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... International Inc. (NYSE: MTD ) today announced second ... , Sales in local currency increased 3% ... sales decreased 4% as currency reduced sales growth by ... diluted share as reported (EPS) were $2.73, compared with ... , an increase of 9% over the prior-year ...
(Date:7/30/2015)... SAN DIEGO , July 30, 2015 /PRNewswire/ ... a medical device company and manufacturer of the ... it has entered into non-exclusive Development Agreements with ... generation Tandem insulin pumps with the Dexcom G5 ... "Integrating Tandem,s next generation pump platform with ...
(Date:7/30/2015)... , July 30, 2015  OncoGenex Pharmaceuticals, Inc. ... report its second quarter 2015 financial results on Thursday, ... call and live webcast at 4:30 p.m. Eastern Time ... programs and a general corporate update. ... Relations page of the OncoGenex website at www.oncogenex.com ...
Breaking Medicine Technology:Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 2Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 3Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 4Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 5Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 6Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 7Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 8Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 9Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 10Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 11Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 12Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 13Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 14Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 2Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 3
... AXA Research Fund closed out its first year of existence. ... 13 million to various European research institutions.The purpose of the ... risks in the world by supporting cutting edge scientific research. ... million over five years, making it a major initiative in ...
... N.J., March 23 Each year in the United States ... myeloma. These new cases account for 10 percent of ... For several types of leukemia, the survival rate has ... James M. Golubieski, president of Foundation Venture Capital Group, LLC, ...
Cached Medicine Technology:First Year Results of the AXA Research Fund: Over Euro 13 Million Allocated for Research in 2008 2First Year Results of the AXA Research Fund: Over Euro 13 Million Allocated for Research in 2008 3Foundation Venture Capital Group Invests in UMDNJ Company Working to Improve Leukemia Treatments 2
(Date:7/31/2015)... ... ... Like nearly every other form of surgery, it shouldn't come as a ... less intrusive and painful. Leading these advances in the United States has been ... as the only doctor in the United States who is qualified to practice, and ...
(Date:7/31/2015)... ... ... The Heart Fit Clinic has increased a patient's fitness level 60 percent ... beats versus 100 beats, this is a big deal," says Diamond Fernandes, director of ... patients with heart disease," he adds. People with angina are able to do a ...
(Date:7/31/2015)... ... July 31, 2015 , ... Burnaby sports physiotherapy clinic, Absolute ... understanding and treatment of ankle sprains. A common sports injury, ankle sprains are ... dangerous if the condition augments and causes more disruption. Absolute PhysioCare’s blog discusses ...
(Date:7/31/2015)... ... July 31, 2015 , ... Awarded to only the Top 10 ... announce that they are the latest recipients of the Center of Clinical Excellence ... of the worldwide leaders in the science of hair transplant. , Parsa Mohebi Hair ...
(Date:7/31/2015)... ... ... is a reputable source of authentic USA vs. Australia tickets at Ford Field ... Team in conjunction with their Victory Tour to celebrate winning the 2015 Women's World Cup ... was awarded the Golden Ball as the best player of the 2015 Women's World Cup. ...
Breaking Medicine News(10 mins):Health News:Loria Medical Penile Enlargement Center to Expand, Offering Practice Partnership to Doctors 2Health News:Heart Fit Clinic Helps Patient Increase Fitness Level with External Counterpulsation 2Health News:Absolute PhysioCare & Sports Rehab Promotes Understanding & Treatment of Ankle Sprains 2Health News:Prestigious Medical Award Given To Parsa Mohebi Hair Restoration for Excellence in Hair Transplantation 2Health News:Cheap USA vs. Australia Tickets at Ford Field in Detroit, MI: Ticket Down Slashes Ticket Prices for Australia vs. USWNT International Friendly Match at Ford Field 2
... Health Care for All Depends on Adequate RN StaffingSILVER SPRING, ... American Nurses, AFL-CIO, pledged to redouble their efforts to secure ... Schakowsky (D-IL) -- that would make federal RN staffing ratios ... Nurses Week, I can think of no better gift for ...
... at American College of Obstetricians and Gynecologists, 57th Annual ... Surgical, Inc., a medical device company that has developed ... technology, released results from a preclinical study demonstrating that ... improved fascia incision healing in an in vivo model ...
... 2009 In a letter to the Editor of the ... by Elsevier, S. Lefebvre and J.S. Weese from the University ... MRSA and C.difficile could be passed between pet ... C. difficile may have been transferred to the ...
... blood clots are often recommended to stop these medications ... However, interruption of these medications can place patients at ... by Shai Friedland at the VA Palo Alto hospital ... without interrupting anticoagulation. Their study will be published on ...
... Elsevier, the world,s leading publisher of scientific, technical, ... Walsh, MSc, FACP, FRCP (Edin) on receiving the ... Project on Death in America (PDIA) Palliative Medicine ... AAHPM 2009 Annual Assembly on March 26. , ...
... Work, Money and the EconomySeven out of 10 ... 7 Economic pressures are having an increasing ... to a new survey by the American Psychological ... reporting significant stress related to work, money, housing ...
Cached Medicine News:Health News:UAN Hails Reintroduction of Federal RN Staffing Ratio Bill and Vows to Work for Passage 2Health News:PEAK Surgical Announces Positive Fascia Incision Healing Results From Preclinical Study of PEAK PlasmaBlade(TM) for Gynecologic Surgery 2Health News:PEAK Surgical Announces Positive Fascia Incision Healing Results From Preclinical Study of PEAK PlasmaBlade(TM) for Gynecologic Surgery 3Health News:PEAK Surgical Announces Positive Fascia Incision Healing Results From Preclinical Study of PEAK PlasmaBlade(TM) for Gynecologic Surgery 4Health News:PEAK Surgical Announces Positive Fascia Incision Healing Results From Preclinical Study of PEAK PlasmaBlade(TM) for Gynecologic Surgery 5Health News:Transmission of MRSA and Clostridium difficile through dogs 2Health News:Author Declan Walsh honored with National Leadership Award in Palliative Medicine 2Health News:APA Poll Finds Economic Stress Taking a Toll on Men 2Health News:APA Poll Finds Economic Stress Taking a Toll on Men 3
... Size: 3.0 x 7.5 x ... Scleral Sponge II line designed by ... material is a closed cell sponge ... are soft with rounded edges to ...
... x 80 mm. Storz offers the ... by Harvey A. Lincoff, M.D. ... sponge which is non-toxic and non-antigenic. ... to minimize scleral intrusion. These implants ...
Thin silicone pad implant. Indications: For closing scleral ruptures. Overall length: 7.8 mm....
... mm. Half oval. The original Scleral Sponge II ... been modified by Dr. Joseph Olk with this ... cell sponge which is non-toxic and non-antigenic. Implants ... intrusion. These implants are packaged sterile and sold ...
Medicine Products: